touchpodcast

touchPODCAST

Science EN ↓ 546 episodes

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005!We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updatesHome...

Author

touchpodcast

Category

Science

Podcast website

touchpodcast.podbean.com

Latest episode

Jul 9, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

Expanding horizons for patients with Pompe disease: Using data to guide clinical practice 18.03.2025

touchCONGRESS for touchENDOCRINOLOGY Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data m...

Expanding horizons for patients with Pompe disease: Using data to guide clinical practice 18.03.2025

touchCONGRESS for touchNEUROLOGY Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data may a...

Expanding horizons for patients with Pompe disease Using data to guide clinical practice 18.03.2025

touchCONGRESS for touchRESPIRATORY Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data may...

MDT perspectives on the importance of patient engagement in PARPi use - Video 3 06.03.2025

touchMDT for touchONCOLOGY Listen to experts Dr Alicia Morgans, Dr Grace Cullen, and patient advocate, Mr Tony Collier, discuss the importance and practicalities of engaging patients in their care and hear insights from the perspective of a patient advocate in relation to the use of PARP inhibitors. The multidisciplinary team and patient advocate: Medical oncologist – Dr Alicia Morgans Dana-Farber...

MDT perspectives on understanding precision medicine to guide PARPi use in mCRPC - Video 2 06.03.2025

touchMDT for touchONCOLOGY   Somatic and germline testing are key in managing metastatic castration-resistant prostate cancer (mCRPC). Listen as Prof. Albrecht Stenzinger shares his perspectives as a pathologist with Dr Alicia Morgan and Dr Grace Cullen.   The multidisciplinary team: Medical oncologist – Dr Alicia Morgans Dana-Farber Cancer Institute, Boston, Massachusetts, USA Nurse practitioner...

MDT perspectives on unlocking the data on PARPi to support shared decision-making in mCRPC - Video 1 06.03.2025

touchMDT for touchONCOLOGY MDT perspectives on unlocking the data on PARPi to support shared decision-making in mCRPC Experts Dr Alicia Morgans and Dr Grace Cullen share insights into using evidence to guide practice and shared decision-making with patients with metastatic castration-resistant prostate cancer (mCRPC). The multidisciplinary team: Medical oncologist – Dr Alicia Morgans Dana-Farber C...

The next frontier in managing obesity and T2D: The role of novel combinations for touchENDOCRINOLOGY 27.02.2025

touchEXPERT OPINIONS for touchENDOCRINOLOGY Listen to three experts discuss the rationale behind glucagon-like peptide-1 (GLP-1)-based combination therapies and review the latest clinical evidence for these novel combinations. The expert faculty will provide their insights on what these combination treatments may mean for the future management of obesity with or without type 2 diabetes (T2D). The...

The next frontier in managing obesity and T2D: The role of novel combinations for touchCARDIO 27.02.2025

touchEXPERT OPINIONS for touchCARDIO Listen to three experts discuss the rationale behind glucagon-like peptide-1 (GLP-1)-based combination therapies and review the latest clinical evidence for these novel combinations. The expert faculty will provide their insights on what these combination treatments may mean for the future management of obesity with or without type 2 diabetes (T2D). The experts...

From clinical trials to clinical practice: Applying CDK4/6 inhibitors in HR+/HER2– early breast cancer 21.02.2025

touchEXPERT OPINIONS for touchONCOLOGY Listen to three experts in breast cancer as they provide insights into the current guideline recommendations for the use of targeted therapy in patients with HR+/HER2– early breast cancer, evaluate the latest data for CDK4/6 inhibitors in this patient population and consider how to maximize the potential of these agents through risk stratification and safety...

Cervical cancer prevention and beyond: Optimizing HPV vaccine uptake in all eligible individuals 20.02.2025

touchIN CONVERSATION for touchINFECTIOUS DISEASES Listen to a paediatrician specializing in adolescent medicine and a general practitioner specializing in sexual health as they address healthcare professionals' questions on HPV vaccination. They provide insights into the burden of HPV-related oncological and non-oncological diseases, appropriate vaccination schedules for specific patient groups, a...

Cervical cancer prevention and beyond: Optimizing HPV vaccine uptake in all eligible individuals 20.02.2025

touchIN CONVERSATION for touchONCOLOGY Listen to a paediatrician specializing in adolescent medicine and a general practitioner specializing in sexual health as they address healthcare professionals' questions on HPV vaccination. They provide insights into the burden of HPV-related oncological and non-oncological diseases, appropriate vaccination schedules for specific patient groups, and strategi...

Looking to the future in the treatment of steroid-refractory chronic GvHD 18.02.2025

touchFOCUS for touchHAEMATOLOGY In this concise interview, Dr Corey Cutler discusses unmet needs in steroid-refractory chronic GvHD and how they may be addressed with new and emerging therapies. The expert: Dr Corey Cutler - Dana-Farber Cancer Institute, Boston, MA, USA This touchPODCAST is for HCPs outside the UK.  This activity is funded by an independent medical education grant from Sanofi US....

Looking to the future in the treatment of steroid-refractory chronic GvHD 18.02.2025

touchFOCUS for touchONCOLOGY In this concise interview, Dr Corey Cutler discusses unmet needs in steroid-refractory chronic GvHD and how they may be addressed with new and emerging therapies. The expert: Dr Corey Cutler - Dana-Farber Cancer Institute, Boston, MA, USA This touchPODCAST is for HCPs outside the UK.  This activity is funded by an independent medical education grant from Sanofi US. Thi...

Updates in BCMA-directed therapies in multiple myeloma from ASH 2024 06.02.2025

touchCONGRESS for ONCOLOGY Multiple myeloma expert Prof. Katja Weisel summarizes key data for BCMA-targeted agents in multiple myeloma presented at the 2024 American Society of Hematology (ASH) Annual Meeting and Exposition. Prof. Weisel is then joined by fellow experts Dr Nisha Joseph and Prof. Roman Hájek to discuss the potential implications of the data for clinical practice.  The experts Prof....

Updates in BCMA-directed therapies in multiple myeloma from ASH 2024 06.02.2025

touchCONGRESS for touchHAEMATOLOGY Multiple myeloma expert Prof. Katja Weisel summarizes key data for BCMA-targeted agents in multiple myeloma presented at the 2024 American Society of Hematology (ASH) Annual Meeting and Exposition. Prof. Weisel is then joined by fellow experts Dr Nisha Joseph and Prof. Roman Hájek to discuss the potential implications of the data for clinical practice.  The exper...

RAS mutations and personalized cancer care: Targeting the future 30.01.2025

touchEXPERT OPINIONS for touchONCOLOGY Listen to a medical oncologist, a pancreatic cancer specialist and a lung cancer specialist discuss the role of RAS mutations in solid tumours, notably pancreatic cancer and NSCLC, and how they may be therapeutically targeted to improve patient outcomes. The experts Dr David S Hong, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Dr Eileen...

What’s new in primary ITP? Key updates from ASH 2024 29.01.2025

touchPANEL DISCUSSION for touchONCOLOGY Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, emerging targeted treatments and the real-world impact of ITP. The faculty share their insights and review the latest data on these topics from the 66th American Society of Hematology Annual Meeting & Exposition.   The experts Dr Hanny Al-Samkari – M...

What’s new in primary ITP? Key updates from ASH 2024 29.01.2025

touchPANEL DISCUSSION for touchHAEMATOLOGY Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, emerging targeted treatments and the real-world impact of ITP. The faculty share their insights and review the latest data on these topics from the 66th American Society of Hematology Annual Meeting & Exposition.   The experts Dr Hanny Al-Samkari...

Focused insights: Data implications of ADCs in NSCLC treatment 24.01.2025

touchFOCUS for touchRESPIRATORY Listen to Prof. Céline Mascaux, an expert in thoracic oncology, answer a series of questions on the latest efficacy and safety data for ADCs in the treatment of patients with NSCLC in the first- and second-line setting, and place these data in the context of current standards of care. She also considers how these data may impact clinical practice in the future. The...

Focused insights: Data implications of ADCs in NSCLC treatment 24.01.2025

touchFOCUS for touchONCOLOGY Listen to Prof. Céline Mascaux, an expert in thoracic oncology, answer a series of questions on the latest efficacy and safety data for ADCs in the treatment of patients with NSCLC in the first- and second-line setting, and place these data in the context of current standards of care. She also considers how these data may impact clinical practice in the future. The exp...

Collaboration in chronic ITP: Improving quality of life and patient outcomes - touchSYMPOSIUM for touchONCOLOGY 21.01.2025

touchSYMPOSIUM for touchHAEMATOLOGY Listen to this touchSYMPOSIUM recorded live in December 2024 preceding the 66th American Society of Hematology Annual Meeting and Exposition in San Diego, CA, USA.  Symposium chair Prof. Cindy Neunert is joined by Dr María Eva Mingot Castellano and Prof. David Kuter to discuss the impact of immune thrombocytopenia (ITP) on patients and review current and emergin...

Collaboration in chronic ITP: Improving quality of life and patient outcomes - touchSYMPOSIUM for touchHAEMATOLOGY 21.01.2025

touchSYMPOSIUM for touchHAEMATOLOGY Listen to this touchSYMPOSIUM recorded live in December 2024 preceding the 66th American Society of Hematology Annual Meeting and Exposition in San Diego, CA, USA.  Symposium chair Prof. Cindy Neunert is joined by Dr María Eva Mingot Castellano and Prof. David Kuter to discuss the impact of immune thrombocytopenia (ITP) on patients and review current and emergin...

Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life - touchONCOLOGY 06.01.2025

touchEXPERT FOCUS for touchONCOLOGY Listen to three experts provide insights into the optimal management of neurofibromatosis type 1 (NF1) in paediatric and adult patients, with a focus on plexiform neurofibromas (PNs). Strategies for ensuring the smooth transitioning of paediatric patients into the adult care system are also considered. The experts Dr AeRang Kim, Children's National Hospital, Was...

Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life - touchNEUROLOGY 06.01.2025

touchEXPERT FOCUS for touchNEUROLOGY Listen to three experts provide insights into the optimal management of neurofibromatosis type 1 (NF1) in paediatric and adult patients, with a focus on plexiform neurofibromas (PNs). Strategies for ensuring the smooth transitioning of paediatric patients into the adult care system are also considered. The experts Dr AeRang Kim, Children's National Hospital, Wa...

Advancing the treatment of muscle-invasive bladder cancer: Updates on immunotherapy in the perioperative setting 19.12.2024

touchEXPERT OPINIONS for touchONCOLOGY Listen to an oncologist, urologist and oncology nurse highlight the key data for immunotherapy in the perioperative setting for muscle-invasive bladder cancer, practical considerations for its use in clinical practice, and how possible side effects can be monitored for and managed. They also consider the role of the multidisciplinary team in implementing this...

Listen to the touchPODCAST podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.